Baird Medical Successfully Conducts Clinical Training Workshops in Indonesia

Written by Emily J. Thompson, Senior Investment Analyst

Source: Newsfilter

Updated: Mar 16 2026

0mins

BDMD+9.95%

Should l Buy BDMD?

Source: Newsfilter

Successful Clinical Training: Baird Medical executed two clinical training workshops in Indonesia at EKA Medika Hospital and RSCM Hospital, providing local physicians with hands-on experience in Microwave Ablation technology, thereby enhancing the company's influence in the Southeast Asian market.
Strategic Expansion: The workshops not only equipped regional healthcare providers with advanced tools and practical knowledge but also facilitated Baird Medical's strategic expansion in Southeast Asia, which is expected to improve patient care quality and drive business growth.
Market Leadership: As a market leader in minimally invasive diagnostics and treatment, Baird Medical's solutions are utilized in over 30 prestigious hospitals in the U.S., further solidifying its competitive advantage in the global medical device market.
Future Development Vision: Baird Medical is committed to fostering strategic collaborations with leading academic institutions to advance the research and development of surgical robotic systems and innovative minimally invasive surgical instruments, aiming to enhance patient outcomes through precision technology and demonstrate its foresight in medical innovation.

Trade with 70% Backtested Accuracy

Stop guessing "Should I Buy BDMD?" and start using high-conviction signals backed by rigorous historical data.

Analyst Views on BDMD

About BDMD

Baird Medical Investment Holdings Ltd is a holding company primarily engaged in the research and development, manufacture and sales of microwave ablation (MWA) medical devices. The Company’s MWA medical devices primarily include MWA needles and MWA therapeutic apparatus. The Company is also engaged in the sales of other medical devices, including catheters, ventilators, operation tables, medical gloves, syringes and other large medical machines and systems. The proprietary medical devices are used for treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer and breast lumps. The Company primarily conducts its businesses in the domestic market.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.

Baird Medical Successfully Hosts Clinical Training in Indonesia

Mar 16 2026PRnewswire

Successful Clinical Training: Baird Medical executed two clinical training workshops in Indonesia, aimed at enhancing the skills of local healthcare providers, thereby improving patient care quality and reinforcing its leadership position in the Southeast Asian market.
Market Expansion Strategy: This training initiative is a key part of the company's strategic expansion into Southeast Asia, providing advanced knowledge of Microwave Ablation technology to help healthcare institutions improve treatment outcomes and meet the growing patient demand.
Technology Promotion: Through these workshops, Baird Medical showcased its expertise in minimally invasive technology to Indonesian healthcare providers, aiming to elevate industry standards through education and training, thus increasing market acceptance of its products.
Strengthening Regional Partnerships: The event not only fostered collaboration with Indonesian healthcare institutions but also laid the groundwork for future business expansion, demonstrating the company's commitment and long-term investment intentions in the Southeast Asian market.